EXHIBIT  31.2

CERTIFICATION  OF  CFO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

     I,  M.  Dwight  Cantrell,  certify  that:

     1.   I  have  reviewed this annual report on Form 10-KSB of Endovasc, Inc.;

     2.   Based  on  my  knowledge,  this  report  does  not  contain any untrue
          statement  of  a  material  fact  or  omit  to  state  a material fact
          necessary  to  make the statements made, in light of the circumstances
          under  which such statements were made, not misleading with respect to
          the  period  covered  by  this  report;

     3.   Based  on  my knowledge, the financial statements, and other financial
          information  included  in  this report, fairly present in all material
          respects the financial condition, results of operations and cash flows
          of  Endovasc,  Inc.  as  of,  and  for,  the periods presented in this
          report;

     4.   Endovasc,  Inc.'s  other  certifying officer and I are responsible for
          establishing  and  maintaining  disclosure controls and procedures (as
          defined  in  Exchange Act Rules 13a-15(e) and 15d-15(e)) for Endovasc,
          Inc.  and  have:

          a)   designed  such disclosure controls and procedures, or caused such
               disclosure  controls  and  procedures  to  be  designed under our
               supervision,  to  ensure  that  material  information relating to
               Endovasc,  Inc.  including its consolidated subsidiaries, is made
               known  to us by others within those entities, particularly during
               the  period  in  which  this  report  is  being  prepared;
          b)   evaluated  the  effectiveness  of  Endovasc,  Inc.'s  disclosure
               controls  and  procedures  and  presented  in  this  report  our
               conclusions  about  the  effectiveness of the disclosure controls
               and  procedures,  as  of  the  end  of the period covered by this
               report  based  on  such  evaluation;  and
          c)   disclosed  in this report any change in Endovasc, Inc.'s internal
               control  over  financial reporting that occurred during Endovasc,
               Inc.'s  most  recent fiscal year that has materially affected, or
               is  reasonably  likely  to  materially  affect,  Endovasc, Inc.'s
               internal  control  over  financial  reporting;  and

     5.   Endovasc,  Inc.'s  other  certifying  officer(s) and I have disclosed,
          based on our most recent evaluation of internal control over financial
          reporting,  to  Endovasc,  Inc.'s  auditors and the audit committee of
          Endovasc,  Inc.'s  Board  of  Directors  (or  persons  performing  the
          equivalent  functions):

          a)   all  significant  deficiencies  and  material  weaknesses  in the
               design  or operation of internal control over financial reporting
               which  are reasonably likely to adversely affect Endovasc, Inc.'s
               ability  to  record,  process,  summarize  and  report  financial
               information;  and
          b)   any  fraud,  whether or not material, that involves management or
               other  employees  who have a significant role in Endovasc, Inc.'s
               internal  control  over  financial  reporting.


Date:  October 14, 2003               /s/ M. Dwight Cantrell
                                      ----------------------------
                                      M.  Dwight  Cantrell,
                                      Chief  Financial  Officer


                                       19
<PAGE>